05/03/2016

Ackman defends Valeant, hints at more changes

Billionaire investor William Ackman on Monday mounted a vigorous defense of Valeant Pharmaceuticals , ruling out any sale of the drug company's "crown jewel" assets but saying price cuts and even a new name may be in its future.